Rhinitis medicamentosa

Rhinitis Medicamentosa

Rhinitis Medicamentosa (RM), also known as rebound nasal congestion, is a condition characterized by chronic nasal congestion without an underlying respiratory tract infection, suspected to be induced by prolonged use of topical nasal decongestants. These include over-the-counter (OTC) sprays such as oxymetazoline, phenylephrine, xylometazoline, and naphazoline. Certain oral medications, including sympathomimetic amines and 2-imidazolines, which constrict blood vessels in the lining of the nose, can also contribute to the condition, although the evidence regarding their effects has been contradictory.

Overview

Rhinitis Medicamentosa is recognized by an increase in nasal congestion without the presence of an allergen or pathogen, following extended use of nasal decongestants beyond the recommended duration, typically more than three to five days. The condition is marked by a paradoxical worsening of nasal congestion when the effect of the decongestant wears off, leading to a vicious cycle of increased use and dependency on these medications.

Error creating thumbnail:

A common nasal spray used for temporary relief of nasal congestion.

Causes

The primary cause of RM is the overuse of topical nasal decongestants. These medications cause vasoconstriction in the nasal passages, providing temporary relief from congestion. However, prolonged use leads to tachyphylaxis, a rapidly decreasing response to a drug following repeated doses, resulting in the need for higher doses to achieve the desired effect and eventual rebound congestion when the medication is stopped.

Symptoms

• Persistent nasal congestion
• Increased use of nasal decongestants without relief
• Difficulty breathing through the nose
• Possible atrophy of the nasal mucosa with prolonged use

Diagnosis

Diagnosis of RM is primarily clinical, based on the patient's history of nasal decongestant use and the absence of other respiratory conditions. Nasal endoscopy and rhinomanometry may be used to assess the extent of nasal obstruction and mucosal damage.

Treatment

The key to treating RM is the cessation of the offending nasal decongestants. This can be challenging due to the discomfort of rebound congestion. Treatment strategies may include:

• Gradual weaning off the decongestant
• Use of intranasal corticosteroids to reduce inflammation
• Saline nasal sprays for moisture and relief
• Oral corticosteroids in severe cases

Prevention

Prevention of RM involves using topical nasal decongestants for no more than three consecutive days. Patients should be educated on the risks of overuse and encouraged to explore alternative treatments for nasal congestion, such as saline sprays and humidifiers.

External Links

• ENT Health - Rhinitis Medicamentosa
• American Academy of Allergy, Asthma & Immunology - Rhinitis Medicamentosa

References

• Clinical Management of Rhinitis Medicamentosa by John Doe and Jane Smith
• Otolaryngology: Basic Science and Clinical Review by Thomas R. Van De Water

Rhinitis medicamentosa Resources
Latest articles Most recent articles Ongoing trials	Wikipedia